|
Senate Bill 773 |
Senate Author: Parker |
|
Effective: 6-18-23 |
House Sponsor: Toth et al. |
Senate Bill 773, the Medical Freedom Act, amends the Health and Safety Code to permit the use of investigational drugs, biological products, and devices by eligible patients who have a severe chronic disease that is designated as such by the commissioner of state health services, whose physician has considered and ruled out all other available treatment options, and who provides written informed consent. The bill provides protections for manufacturers of an investigational drug, biological product, or device and for persons or entities involved in the care of an eligible patient regarding access to and treatment with such a drug, product, or device. Additionally, the bill prohibits the state from interfering with an eligible patient's access to an investigational drug, biological product, or device unless it is adulterated or misbranded.